» Articles » PMID: 28144971

Long-term Complications of Stevens-Johnson Syndrome/toxic Epidermal Necrolysis (SJS/TEN): the Spectrum of Chronic Problems in Patients Who Survive an Episode of SJS/TEN Necessitates Multidisciplinary Follow-up

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 2017 Feb 2
PMID 28144971
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe adverse reactions to drugs that cause a life-threatening eruption of mucocutaneous blistering and epithelial sloughing. While the acute complications of SJS/TEN are well described, it is increasingly recognized that survivors may develop delayed sequelae, some of which can be associated with significant morbidity. Studies of long-term SJS/TEN outcomes mostly focus on mucocutaneous and ocular complications. However, other internal organs, such as the respiratory tract and gastrointestinal tract, can be affected. Psychological sequelae are also frequent following the trauma of widespread epidermal necrolysis. An appreciation of the 'chronic' phase of SJS/TEN is needed by clinicians caring for individuals who have survived the acute illness. This review aims to provide an update on the breadth and range of sequelae that can affect patients in the months and years following an acute episode of SJS/TEN.

Citing Articles

Risk of Cardiovascular Morbidity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Survivors.

Chiu H, Chiu Y JAMA Dermatol. 2025; .

PMID: 39969876 PMC: 11840681. DOI: 10.1001/jamadermatol.2024.5881.


Update on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management.

Shah H, Parisi R, Mukherjee E, Phillips E, Dodiuk-Gad R Am J Clin Dermatol. 2024; 25(6):891-908.

PMID: 39278968 PMC: 11511757. DOI: 10.1007/s40257-024-00889-6.


Trastuzumab-induced toxic epidermal necrolysis in a Her-2-positive metastatic breast cancer patient-A rare case report.

Ferdause J, Momtahena S, Karim R, Chowdhury A, Hossain N, Islam M Clin Case Rep. 2024; 12(7):e9103.

PMID: 38915931 PMC: 11194292. DOI: 10.1002/ccr3.9103.


Severe cutaneous adverse reactions.

Hung S, Mockenhaupt M, Blumenthal K, Abe R, Ueta M, Ingen-Housz-Oro S Nat Rev Dis Primers. 2024; 10(1):30.

PMID: 38664435 DOI: 10.1038/s41572-024-00514-0.


Dipyrone (Metamizole)-Induced Stevens-Johnson Syndrome.

Gomes Ferreira S, Fernandes L, Santos S, Ferreira S, Sequeira J Cureus. 2024; 16(1):e53122.

PMID: 38420072 PMC: 10899118. DOI: 10.7759/cureus.53122.